Sarah Delaplane is an accomplished inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the area of microbial metabolic pathways. With a total of 2 patents, her work focuses on genetic modifications that enhance the production of valuable compounds.

Latest Patents

Delaplane's latest patents include a process to prepare elongated 2-ketoacids and C-5-C10 compounds via genetic modifications to microbial metabolic pathways. This patent describes genetically modified LeuCD' enzyme complexes and processes for preparing a C-C2-ketoacid utilizing these modified enzyme complexes. The microbial organisms that include these modified LeuCD enzyme complexes can be particularly useful for producing C-Caldehydes, alkanes, alcohols, and carboxylic acids, both in vivo and in vitro. Another significant patent involves genetically modified isopropylmalate synthases, which also focus on preparing C-C2-ketoacids. These processes and organisms can be beneficial for producing corresponding Caldehydes, alcohols, carboxylic acids, and Calkanes.

Career Highlights

Sarah Delaplane is currently employed at Dow Global Technologies LLC, where she continues to innovate and develop new biotechnological processes. Her expertise in genetic modifications has positioned her as a key player in her field.

Collaborations

Delaplane has collaborated with notable colleagues such as Paresh C Sanghani and Eric C Shiue, contributing to the advancement of their shared research goals.

Conclusion

Sarah Delaplane's innovative work in biotechnology and her contributions to genetic modifications highlight her role as a leading inventor in her field. Her patents reflect a commitment to advancing scientific knowledge and practical applications in microbial metabolic pathways.

Profile summary based on public USPTO records.